40 percent of the biopharmaceutical industry's growth over the next five years will be in emerging markets. How will the industry help developing countries achieve their healthcare goals? Listen to Samir Khalil, executive director, public policy, Asia Pacific & China at Merck discuss his important work with China to build appropriate guidelines for disease treatment and increase access to medicines.
